Haemoglobin A1c and the diagnosis of diabetes mellitus

Conventionally diabetes mellitus has been diagnosed by high fasting or random blood glucose concentrations, or abnormal oral glucose tolerance tests (OGTT). Haemoglobin A1c (HbA1c) has been used to monitor longer term glycaemic control in patients with known diabetes mellitus.

In 2011, the World Health Organisation (WHO 2011) recommended that HbA1c measurements should also be used to diagnose diabetes in the majority of asymptomatic individuals, and this recommendation has been agreed in the UK (NHS Diabetes 2011).

HbA1c of 48 mmol/mol or more (≥ 6.5%) is consistent with diabetes: if the patient has no symptoms then a second HbA1c result must be obtained within 2 weeks, and if ≥ 48 mmol/mol (≥ 6.5%) confirms diabetes mellitus.

HbA1c values of 42 to 47 mmol/mol (6.0 to 6.4%) suggest a high risk of future diabetes. Such individuals should be offered structured lifestyle education and support to delay/prevent development of diabetes, and have an annual HbA1c test

HbA1c must be measured in an accredited laboratory undertaking recommended quality assurance procedures. Near patient testing is not appropriate when HbA1c is used for the diagnosis of diabetes.

HbA1c is now the preferred method to diagnose diabetes, except in the following situations where this test would be unreliable, and in whom the traditional methods of diagnosis with blood glucose concentrations remain the method of choice:

  • Haemoglobinopathies
  • Increased red cell turnover
  • Anaemia (haemoglobin < 8 g/dL)
  • ?Type 1 diabetes or acute onset of symptoms of diabetes
  • ?Gestational diabetes
  • Children and adolescents
  • Patients taking steroids and antipsychotics or other medications that cause rapid rise in blood glucose

Despite this new approach, if an individual has abnormally high random or fasting blood glucose levels or abnormal OGTTs, which would be consistent with diabetes on the traditional criteria, then that patient should be considered to have diabetes irrespective of their HbA1c value. Without symptoms of diabetes two abnormal tests of the same type (two high fasting or random blood glucoses or a diabetic OGTT) are required to confirm diabetes mellitus.

A flow sheet for the diagnosis of diabetes is attached.

References

NHS Diabetes (2011) Use of Haemoglobin A1c (HbA1c) in the diagnosis of diabetes http://www.diabetes.nhs.uk/news_and_events/use_of_haemoglobin_a1c_hba1c_in_the_diagnosis_of_diabetes_mellitus_the_implementation_of_world_health_organisation_who_guidance_2011/

Use of Glycated Haemoglobin (HbA1c) in the diagnosis of Diabetes Mellitus www.who.int/diabetes/publications/report-hba1c_2011.pdf

biochemistry, specialist testing, clinical advice

  • Created on .
  • Last updated on .

Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018

HTA licence number is 12366

Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.

The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS Logos